Impact of standard-dose dipeptidyl peptidase-4 inhibitors on the incidence of graft-versus-host disease after allogeneic hematopoietic cell transplantation
Authors:
- Shun-Ichi KimuraSKShun-Ichi Kimura
- Masatoshi SakuraiMSMasatoshi Sakurai
- Kensuke KayamoriKKKensuke Kayamori
- Chikako OhwadaCOChikako Ohwada
- Kazuki YoshimuraKYKazuki Yoshimura
- Hideki NakasoneHNHideki Nakasone
- Takuma OhashiTOTakuma Ohashi
- Katsuhiro ShonoKSKatsuhiro Shono
- Takayoshi TachibanaTTTakayoshi Tachibana
- 26 December 2022
- journal article
- letter
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 58 (4) , 452-455
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Dipeptidyl peptidase‐4 inhibitors lower the risk of autoimmune disease in patients with type 2 diabetes mellitus: A nationwide population‐based cohort studyBritish Journal of Clinical Pharmacology, 2019
- High-dose sitagliptin for systemic inhibition of dipeptidylpeptidase-4 to enhance engraftment of single cord umbilical cord blood transplantationOncotarget, 2017
- Dipeptidyl peptidase-4 inhibitors in type 2 diabetes may reduce the risk of autoimmune diseases: a population-based cohort studyAnnals of the Rheumatic Diseases, 2015
- NIH Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. The 2014 Pathology Working Group ReportTransplantation and Cellular Therapy, 2015
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group ReportTransplantation and Cellular Therapy, 2015
- In Vivo DPP-4 Inhibition to Enhance Engraftment of Single-Unit Cord Blood Transplants in Adults with Hematological MalignanciesStem Cells and Development, 2013
- CD26‐mediated co‐stimulation in human CD8+T cells provokes effector function via pro‐inflammatory cytokine productionImmunology, 2013
- Pharmacokinetics and pharmacodynamics of sitagliptin, an inhibitor of dipeptidyl peptidase IV, in healthy subjects: Results from two randomized, double-blind, placebo-controlled studies with single oral dosesClinical Pharmacology & Therapeutics, 2005
- Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppressionBlood, 1981
- CHRONIC CUTANEOUS GRAFT VERSUS HOST DISEASE IN MAN1978